Status:

UNKNOWN

Anxiety Self-management Intervention for Pulmonary Hypertension

Lead Sponsor:

University of Sheffield

Conditions:

Pulmonary Hypertension

Pulmonary Arterial Hypertension

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Pulmonary hypertension (PH) is a disorder of high blood pressure that impacts the heart and lungs. Approximately, 50% of individuals with PH experience anxiety or panic disorders. There is limited evi...

Detailed Description

Project Objectives The primary aim of this study is to develop a self-management intervention in collaboration with patient, public involvement, which will consist of experts by experience and experts...

Eligibility Criteria

Inclusion

  • • Aged 18 years or over
  • Diagnosis of pulmonary hypertension - participants will be asked to self-report this information
  • Able to complete the self-report questionnaires without help from others
  • Able to give informed consent - given that participants need to be proactive in entering the study, this will be assumed.
  • Literate in English

Exclusion

  • • Significant risk issues (participants will be asked to self-report this information), for example, experiencing current thoughts of self-harm or suicide.

Key Trial Info

Start Date :

August 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2021

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT04450862

Start Date

August 5 2020

End Date

August 30 2021

Last Update

November 10 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Clinical Psychology Unit

Sheffield, South Yorkshire, United Kingdom, S1 2LT

2

Clinical Psychology Unit

Sheffield, United Kingdom

Anxiety Self-management Intervention for Pulmonary Hypertension | DecenTrialz